![Henning Walczak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henning Walczak is the founder of Apogenix AG, founded in 2005.
Former job includes Head-BioFuture Research Group at German Cancer Research Center.
| Bedrijven | Functie | Einde |
|---|---|---|
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services Offers biomedical research services | Corporate Officer/Principal | - |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Apogenix AG
Apogenix AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases | Health Technology |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services Offers biomedical research services | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
